Handelsbanken Fonder
ORGO icon

Handelsbanken Fonder’s Organogenesis Holdings ORGO Stock Holding History

Handelsbanken Fonder’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-26,600
Closed -$86K – 1590
2022
Q3 		$86K Hold
26,600
– – ﹤0.01% 1536
2022
Q2 		$130K Hold
26,600
– – ﹤0.01% 1559
2022
Q1 		$203K Hold
26,600
– – ﹤0.01% 1631
2021
Q4 		$246K Buy
+26,600
New +$283K ﹤0.01% 1661

Other funds holding ORGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder's ORGO Position: Q4 2022 in Review

Handelsbanken Fonder sold out of Organogenesis Holdings (ORGO) in Q4 2022, closing a stake of 26,600 shares — an estimated $86K sold.

Handelsbanken Fonder first reported a position in ORGO in Q4 2021 and held it in 4 quarters. The position peaked at $246K in Q4 2021. 150 funds tracked by Wall St. Rank hold ORGO as of Q4 2022.

  • Handelsbanken Fonder reported no remaining Organogenesis Holdings position as of Q4 2022 after selling out during the quarter.
  • Handelsbanken Fonder sold 26,600 Organogenesis Holdings shares in Q4 2022, an estimated $86K.
  • Handelsbanken Fonder first reported a position in Organogenesis Holdings in Q4 2021 and held it in 4 quarters.
  • Handelsbanken Fonder's Organogenesis Holdings position peaked at $246K in Q4 2021.
  • 150 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q4 2022.

Based on Handelsbanken Fonder's 13F filing for Q4 2022, filed 7 Feb 2023.